BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

684 related articles for article (PubMed ID: 8844728)

  • 1. Evaluation and management of multinodular goiter.
    Hurley DL; Gharib H
    Otolaryngol Clin North Am; 1996 Aug; 29(4):527-40. PubMed ID: 8844728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multinodular goiter management in Western Saudi Arabia.
    Qari FA
    Saudi Med J; 2005 Mar; 26(3):438-41. PubMed ID: 15806215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The surgical treatment of the nodular goiter].
    Pelizzo MR; Toniato A; Piotto A; Pagetta C; Ide EC; Boschin IM; Bernante P
    Ann Ital Chir; 2008; 79(1):13-6. PubMed ID: 18572733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyroid nodular disease: is it toxic or nontoxic, malignant or benign?
    Hurley DL; Gharib H
    Geriatrics; 1995 Jun; 50(6):24-6, 29-31. PubMed ID: 7768463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diagnosis and therapy of patients with euthyroid goiter].
    Hermus AR; Huysmans DA
    Ned Tijdschr Geneeskd; 2000 Aug; 144(34):1623-7. PubMed ID: 10972051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High prevalence of side effects after recombinant human thyrotropin-stimulated radioiodine treatment with 30 mCi in patients with multinodular goiter and subclinical/clinical hyperthyroidism.
    Romão R; Rubio IG; Tomimori EK; Camargo RY; Knobel M; Medeiros-Neto G
    Thyroid; 2009 Sep; 19(9):945-51. PubMed ID: 19678745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of serum paraoxonase activity with insulin sensitivity and oxidative stress in hyperthyroid and TSH-suppressed nodular goitre patients.
    Yavuz DG; Yüksel M; Deyneli O; Ozen Y; Aydin H; Akalin S
    Clin Endocrinol (Oxf); 2004 Oct; 61(4):515-21. PubMed ID: 15473886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Radioiodine treatment of hyperthyroidism using a simplified dosimetric approach. Clinical results].
    Giovanella L; De Palma D; Ceriani L; Vanoli P; Garancini S; Tordiglione M; Tarolo GL
    Radiol Med; 2000 Dec; 100(6):480-3. PubMed ID: 11307510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis and prevention of recurrent goiter.
    Kraimps JL; Marechaud R; Gineste D; Fieuzal S; Metaye T; Carretier M; Barbier J
    Surg Gynecol Obstet; 1993 Apr; 176(4):319-22. PubMed ID: 8460405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levothyroxine suppressive therapy in the medical management of nontoxic benign multinodular goiter.
    Celani MF
    Exp Clin Endocrinol; 1993; 101(5):326-32. PubMed ID: 8299711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nodular goiter and goiter nodules: Where iodine deficiency falls short of explaining the facts.
    Derwahl M; Studer H
    Exp Clin Endocrinol Diabetes; 2001; 109(5):250-60. PubMed ID: 11507648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of administering 0.2 mg of recombinant human TSH for two consecutive days as an adjuvant to therapy with low radioiodine doses in elderly out-patients with large nontoxic multinodular goiter.
    Giusti M; Cappi C; Santaniello B; Ceresola E; Augeri C; Lagasio C; Minuto F
    Minerva Endocrinol; 2006 Sep; 31(3):191-209. PubMed ID: 17213787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Animal models of disease: feline hyperthyroidism: an animal model for toxic nodular goiter.
    Peterson ME
    J Endocrinol; 2014 Nov; 223(2):T97-114. PubMed ID: 25297557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multinodular goiter.
    Day TA; Chu A; Hoang KG
    Otolaryngol Clin North Am; 2003 Feb; 36(1):35-54. PubMed ID: 12803008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interrelationship between thyroid nodularity and TSH level.
    Sachmechi I; Vahedi M; Nalamasu S; Vuppalanchi R
    Mt Sinai J Med; 2005 Jan; 72(1):33-5. PubMed ID: 15682260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and management of large toxic multinodular goiters.
    Hamburger JI; Hamburger SW
    J Nucl Med; 1985 Aug; 26(8):888-92. PubMed ID: 2411889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single, very low dose (0.03 mg) of recombinant human thyrotropin (rhTSH) effectively increases radioiodine uptake in the I-131 treatment of large nontoxic multinodular goiter.
    Mojsak MN; Abdelrazek S; Szumowski P; Rogowski F; Sykała M; Kostecki J; Kociura-Sawicka A; Jurgilewicz D; Myśliwiec J
    Nucl Med Rev Cent East Eur; 2016; 19(1):3-11. PubMed ID: 26841373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Etiopathology, clinical features, and treatment of diffuse and multinodular nontoxic goiters.
    Knobel M
    J Endocrinol Invest; 2016 Apr; 39(4):357-73. PubMed ID: 26392367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Multinodular goiters].
    Leclere J
    Rev Prat; 2005 Jan; 55(2):167-73. PubMed ID: 15825997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Goiter and nodular thyroid disease: clinical guidelines for diagnosis and treatment. (Waiting? Hormone therapy? Surgery? radioiodine?)].
    Cattaneo F; Bürgi U; Mueller B
    Ther Umsch; 1999 Jul; 56(7):356-63. PubMed ID: 10434771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.